Free Newsletter
Drug theft costs pharma $71B yearly
Counterfeit drugs and outright theft cost the pharmaceuticals industry some $71 billion a year, according to a new study from a consumer advocacy group known as America's Watchdog.
Counterfeiting alone pilfers some $70 billion from drug makers pockets, the group estimated. The remainder? A phenomenon known as "diversion," in which contract manufacturers agreed to make, say, 1 million pills but make 1.5 million instead, selling the extras on the black market--usually via the Internet. Drug makers are working hard to fight this problem, using RFID tags and other inventory control measures, the group said.!-->
- see this article from in-PharmaTechnologist.com
Related Articles:
Counterfeit drugs plaguing Big Pharma
Chinese pharma recalls counterfeit drug
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: